SPY458.10+4.68 1.03%
DIA352.13+5.89 1.70%
IXIC15,153.38+67.91 0.45%

--JMP Securities Adjusts Taysha Gene Therapies' Price Target to $38 from $40, Keeps Market Outperform Rating

MT Newswires · 11/11/2021 05:37

Please log in to view news